Invention Grant
- Patent Title: Soluble IGF receptor Fc fusion proteins and uses thereof
-
Application No.: US14365250Application Date: 2012-12-14
-
Publication No.: US10538575B2Publication Date: 2020-01-21
- Inventor: Pnina Brodt , Bernard Massie , Traian Sulea
- Applicant: THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY , THE NATIONAL RESEARCH COUNCIL OF CANADA
- Agency: Norton Rose Fulbright Canada
- Agent Marie-Helene Rochon
- International Application: PCT/CA2012/050899 WO 20121214
- International Announcement: WO2013/086636 WO 20130620
- Main IPC: A61K38/16
- IPC: A61K38/16 ; C07K14/71 ; A61K35/28 ; A61K39/395 ; A61K45/06 ; C07K16/22 ; A61K48/00 ; A61K35/12 ; A61K39/00
Abstract:
There are described herein novel soluble IGF receptor Fc fusion proteins and compositions and methods of use thereof for treating angiogenesis associated disorders and malignant disease, such as cancer and metastasis, wherein the fusion proteins bind specifically to IGF-1 or IGF-2.
Public/Granted literature
- US20150044209A1 SOLUBLE IGF RECEPTOR Fc FUSION PROTEINS AND USES THEREOF Public/Granted day:2015-02-12
Information query
IPC分类:
